Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07661602Phase 3Not yet recruiting
Phase 3, randomised, open-label trial in anemia (3 arms), sponsored by Southern Medical University. Primary endpoint: Change in hemoglobin concentration at 12 weeks. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07661602.